Price $9.44 |
Market Cap
791.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
17.96
|
P/S
2.79
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-79.5K
|
FCF
-1.4
|
|
Op. Margin
-58.40%
|
Net Margin
-60.80%
|
ROE
-147.10%
|
ROI
-33.40%
|
|
ROA
-30.40%
|
EPS Growth
-39.10%
|
Current Ratio
3.3
|
Debt/Equity
411.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biomerica Inc (BMRA) | $3.16 | - | - | 33.9M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.61 | - | - | 52.7M | Strong Buy |
| Great Elm Group Inc (GEG) | $2.05 | - | - | 58.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.16 | - | - | 152.2M | Strong Buy |
| Harrow Health Inc (HROW) | $8.21 | - | - | 180.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
